Ultra Medica Pharmaceutical Industries / Products

Ultra Medica Pharmaceutical Industries

 


 


 


 


 
 


 


Products » » Respiratory Tract Drugs

Product Search

Drug Index A to Z

Filter:
All 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Solimux ( Carbocisteine )

  • Effective Material
    Carbocisteine
  • Caliber
    Each capsule contains Carbocisteine 375 mg.
  • Pharmacologic Form
    - Mucosolvan
  • Therapeutic Categories
    Respiratory Tract Drugs
  • Pharmaceutical Form
    Capsules
COMPOSITION
Each capsule contains Carbocisteine 375 mg.
EXCIPIENTS
Magnesium stearate, silica colloidal anhydrous, lactose mono hydrate, sodium lauryl sulphate.
MECHANISM OF ACTION
Carbocisteine(S-carboxymethyl L-cysteine) has been shown affect to the nature and amount of mucus glycoprotein which is secreted by the respiratory tract. The administration of carbocisteine to animals exposed to irritants indicates that the glycoprotein that is secreted remains normal administration after exposure indicates that return to the normal state is accelerated. Studies in human have demonstrated that carbocisteine  reduces goblet cell hyperplasia. Carbocisteine can therefore be demonstrated to have a role in the management of disorders characterized by abnormal mucus.
PHARMACOKINETICS
Carbocisteine is rapidly absorbed from the GI tract.
INDICATIONS
Solimux is mucolytic agent for the adjunctive Therapy of respiratory tract disorders characterized by excessive, viscous mucus, including chronic obstructive airways disease.
CONTRAINDICATIONS
Solimux contraindicated in the following states:
- Patients with hypersensitivity to the active substance(s) or to any of the excipients.
 Patients with active peptic ulceration.   
ADVERSE REACTIONS
Immune System Disorders: Anaphylactic reactions and fixed drug eruption.
Skin and subcutaneous tissue disorders: Skin rashes and allergic skin eruptions.
Gastrointestinal disorders: Gastrointestinal bleeding occurring during treatment
WARNING & PRECAUTION
Patients with rare hereditary problems of galactose intolerance, lactase deficiency or glucose-galactose malabsorption should not take this medicine.
Dosage & Administration
Adults including the elderly
Dosage is based upon an initial daily dosage of 2250mg carbocisteine in divided doses, reducing to 1500 mg daily in divided doses when a satisfactory response is obtained e.g. two capsules three times a day.
Children:
This strength is not recommended for children.
OVERDOSE
Gastric lavage may be beneficial, followed by observation. Gastrointestinal disturbance is the most likely symptom of Carbocisteine overdosage.
PACKAGE
Carton pack contains 20 capsules.
STORAGE
Store below 25°C.